Dermapharm Holding SE
DMPHF
$38.50
-$2.12-5.23%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 191.06M | 124.49M | 126.20M | 132.24M | 177.61M |
| Total Receivables | 139.07M | 140.57M | 117.44M | 138.88M | 121.32M |
| Inventory | 411.42M | 379.03M | 355.50M | 386.86M | 375.78M |
| Prepaid Expenses | -- | -- | 7.87M | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 36.59M | 37.10M | 7.44M | 36.97M | 70.10M |
| Total Current Assets | 778.14M | 681.19M | 614.45M | 694.95M | 744.82M |
|
|
|||||
| Total Current Assets | 778.14M | 681.19M | 614.45M | 694.95M | 744.82M |
| Net Property, Plant & Equipment | 369.47M | 342.04M | 326.15M | 354.06M | 345.52M |
| Long-term Investments | 676.77M | 623.07M | 596.73M | 645.20M | 619.82M |
| Goodwill | 676.77M | 623.07M | 596.73M | 645.20M | 619.82M |
| Total Other Intangibles | 583.97M | 544.82M | 420.48M | 579.82M | 565.82M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 75.06M | 68.62M | 173.00M | 67.60M | 63.85M |
| Total Assets | 2.51B | 2.28B | 2.15B | 2.37B | 2.36B |
|
|
|||||
| Total Accounts Payable | 118.31M | 105.40M | 98.13M | 102.78M | 99.83M |
| Total Accrued Expenses | -- | -- | 70.08M | -- | -- |
| Short-term Debt | 11.70K | -- | 36.20K | -- | 25.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 99.36M | 85.94M | 94.38M | 134.89M | 124.87M |
| Total Finance Division Other Current Liabilities | 205.45M | 140.20M | 75.83M | 180.49M | 246.27M |
| Total Other Current Liabilities | 205.45M | 140.20M | 75.83M | 180.49M | 246.27M |
| Total Current Liabilities | 423.13M | 331.53M | 338.46M | 418.16M | 471.00M |
|
|
|||||
| Total Current Liabilities | 423.13M | 331.53M | 338.46M | 418.16M | 471.00M |
| Long-Term Debt | 1.07B | 989.85M | 918.01M | 1.01B | 1.02B |
| Short-term Debt | 11.70K | -- | 36.20K | -- | 25.70K |
| Capital Leases | 16.46M | -- | 12.78M | -- | 14.27M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 287.51M | 266.94M | 254.43M | 283.90M | 267.07M |
| Total Liabilities | 1.80B | 1.59B | 1.52B | 1.71B | 1.77B |
|
|
|||||
| Common Stock & APIC | 63.23M | 58.19M | 55.74M | 60.05M | 57.69M |
| Retained Earnings | 514.15M | 504.32M | 448.48M | 460.28M | 407.94M |
| Treasury Stock & Other | 136.94M | 127.67M | 121.54M | 130.69M | 125.35M |
| Total Common Equity | 714.33M | 690.19M | 625.76M | 651.02M | 590.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 714.33M | 690.19M | 625.76M | 651.02M | 590.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -3.24M | 3.96M | 4.01M | 5.95M | 5.22M |
| Total Equity | 711.08M | 694.15M | 629.77M | 656.97M | 596.20M |
|
|
|||||